| 2J2C |
2.2 |
Crystal structure of Human Cytosolic 5'-Nucleotidase II (NT5C2, cN-II) |
| 2JC9 |
1.5 |
Crystal structure of Human Cytosolic 5'-Nucleotidase II in complex with adenosine |
| 2JCM |
2.15 |
Crystal structure of Human Cytosolic 5'-Nucleotidase II in complex with beryllium trifluoride |
| 2XCV |
2.3 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inosine monophosphate and 2,3-bisphosphoglycerate |
| 2XCW |
1.9 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inosine monophosphate and ATP |
| 2XCX |
2.3 |
Crystal structure of the apoform of the D52N variant of cytosolic 5'- nucleotidase II |
| 2XJB |
2.3 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with deoxyguanosine monophosphate and deoxyadenosine triphosphate |
| 2XJC |
2.0 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with guanosine monophosphate and diadenosine tetraphosphate |
| 2XJD |
2.0 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with inorganic phosphate and deoxyadenosine triphosphate |
| 2XJE |
2.3 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II in complex with uridine 5'-monophosphate and adenosine triphosphate |
| 2XJF |
2.1 |
Crystal structure of the D52N variant of cytosolic 5'-nucleotidase II with a covalently modified Asn52 |
| 4H4B |
2.9 |
Human cytosolic 5'-nucleotidase II in complex with Anthraquinone-2,6- disulfonic acid |
| 5CQZ |
2.9 |
Human cytosolic 5'-nucleotidase II in complex with 3-(3-Imidazol-1-ylphenyl)-N-(9H-purin-6-yl)benzamide |
| 5CR7 |
2.9 |
Human cytosolic 5'-nucleotidase II in complex with N-(9H-Purin-6-yl)-3-(3-pyrrol-1-ylphenyl)benzamide |
| 5K7Y |
1.79 |
Crystal structure of enzyme in purine metabolism |
| 5L4Z |
1.84 |
Crystal structure of enzyme in purine metabolism |
| 5L50 |
1.643 |
Crystal structure of enzyme in purine metabolism |
| 5OPK |
1.74 |
Crystal structure of D52N/R367Q cN-II mutant bound to dATP and free phosphate |
| 5OPL |
1.8 |
Crystal structure of K25E cN-II mutant |
| 5OPM |
1.68 |
Crystal structure of D52N/R238W cN-II mutant bound to dATP and free phosphate |
| 5OPN |
1.77 |
Crystal structure of R39Q cN-II mutant |
| 5OPO |
2.0 |
Crystal structure of R238G cN-II mutant |
| 5OPP |
1.7 |
Crystal structure of S408R cN-II mutant |
| 6DD3 |
1.98 |
Crystal structure of the double mutant (D52N/D407A) of NT5C2-537X in the active state |
| 6DDB |
2.8 |
Crystal structure of the double mutant (D52N/R367Q) of NT5C2-537X in the basal state, Northeast Structural Genomics Consortium Target |
| 6DDC |
2.91 |
Crystal structure of the single mutant (D52N) of NT5C2-537X in the basal state, Northeast Structural Genomics Consortium Target |
| 6DDH |
2.35 |
Crystal structure of the double mutant (D52N/R367Q) of NT5C2-537X in the active state, Northeast Structural Genomics Target |
| 6DDK |
2.5 |
Crystal structure of the double mutant (D52N/R367Q) of the full-length NT5C2 in the basal state |
| 6DDL |
2.26 |
Crystal structure of the single mutant (D52N) of NT5C2-Q523X in the basal state |
| 6DDO |
2.48 |
Crystal structure of the single mutant (D52N) of the full-length NT5C2 in the basal state |
| 6DDQ |
2.31 |
Crystal structure of the double mutant (R39Q/D52N) of the full-length NT5C2 in the basal state |
| 6DDX |
2.901 |
Crystal structure of the double mutant (D52N/L375F) of NT5C2-537X in the active state, Northeast Structural Genomics Target |
| 6DDY |
1.803 |
Crystal structure of the double mutant (D52N/K359Q) of NT5C2-537X in the active state, Northeast Structural Genomics Target |
| 6DDZ |
1.97 |
Crystal structure of the double mutant (D52N/R238W) of NT5C2-537X in the active state, Northeast Structural Genomics Target |
| 6DE0 |
2.05 |
Crystal structure of the single mutant (D52N) of NT5C2-Q523X in the active state |
| 6DE1 |
2.151 |
Crystal structure of the single mutant (D52N) of the full-length NT5C2 in the active state |
| 6DE2 |
2.1 |
Crystal structure of the double mutant (D52N/L375F) of the full-length NT5C2 in the active state |
| 6DE3 |
3.06 |
Crystal structure of the double mutant (R39Q/D52N) of the full-length NT5C2 in the active state |
| 6FIR |
2.5 |
Human cytosolic 5'-nucleotidase II soaked with 5mM3-Phenyl-N-(9H-purin-6-yl)benzamide |
| 6FIS |
2.3 |
Human cytosolic 5'-nucleotidase II soaked with 10mM 7-Benzyloxymethyl-7H-adenine |
| 6FIU |
2.5 |
Human cytosolic 5'-nucleotidase II soaked with 10mM 2-(6-([1,1'-Biphenyl]-3-carboxamido)-9H-purin-9-yl)acetic acid |
| 6FIW |
2.2 |
Human cytosolic 5'-nucleotidase II co-crystallized with 10mM Sodium ((4-(3'-((7H-purin-6-yl)carbamoyl)-[1,1'-biphenyl]-3-yl)-1H-imidazol-1-yl) methyl) phosphonate |
| 6FXH |
2.3 |
Human cytosolic 5'-nucleotidase II soaked with 10mM 3-Phenyl-N-(9H-purin-6-yl)benzamide |
